IKK-dependent activation of NF-kB pathway is a promising target for drug development since it is involved in chronic inflammation conditions, such as inflammatory bowel disease, asthma, rheumatoid arthritis43, 44 and cancer45. Here, NFKB1 is linked to inflammatory bowel disease.